INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
WW
Weibel Paul Wesley IIIChief Executive Officer
FEAM5E Advanced Materials, Inc.
Option exercise
M—
530 sh
Sep 15, 2026
Page 357 of 1689
← PrevNext →
Sep 15, 2026
traded Sep 15, 2026
+0d
SEC Form 4

Evidence

9
FE
Farid Fady Adel EdwardChief Strategy Officer
SSRMSSR MINING INC.
Grant or award
A—
68 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
111 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
22 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
BR
Booth Brian RDirector
SSRMSSR MINING INC.
Grant or award
A—
89 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
PT
Poleg TamirDirector, Chief Executive Officer
REAXReal REMAX Group Inc.
Option exercise
M—
5,392 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

9
SA
Swager Karen ADirector
SSRMSSR MINING INC.
Grant or award
A—
73 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SK
Streich Julie KDirector
APOGAPOGEE ENTERPRISES, INC.
Grant or award
A—
2,530 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,645
1,024 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
TJ
Thomopoulos JoanneEVP, Human Resources
SSRMSSR MINING INC.
Grant or award
A—
14 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

8
FK
Fleming KarenPRES, CMO ROSS DRESS FOR LESS
ROSTROSS STORES, INC.
Tax withholding
F$209K
907 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

8
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$6,100
100 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

6
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Option exercise
M—
125.0K sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Option exercise
M—
37.8K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
MP
Mullen John PPresident
GWREGuidewire Software, Inc.
Option exercise
M—
75.2K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M—
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M$14K
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$27K
13.8K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

4
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Open-market sale · 10b5-1 plan
SELL$80K
960 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$24K
18.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
BW
Boyer David W.Chief Corp. Affairs Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
3,587 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
AM
Abernethy MattChief Financial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
5,020 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Option exercise
M—
22.4K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift · 10b5-1 plan
G—
8,800 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Tax withholding · 10b5-1 plan
F$482K
31.5K sh
Sep 12, 2026Sep 15, 2026
traded Sep 12, 2026
+3dSEC Form 4

Evidence

2
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Option exercise
M—
123.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$630K
50.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$122K
15.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

1
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
9,119 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence